# Avery Dennison Corp: Form 10-Q for the period ended Jul 2, 2022

- Company: [Avery Dennison Corp](/companies/avy.md) (CIK 8818)
- Form: 10-Q
- Filed: 2022-08-02
- Accepted by EDGAR: Aug 2, 2022, 16:06 ET
- Period: 2022-07-02
- Accession: 0000008818-22-000012
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/8818/000000881822000012/avy-20220702.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/8818/000000881822000012/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-07-02.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2022-04-03 to 2022-07-02 | $2.35bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months, 2022-01-02 to 2022-07-02 | $4.70bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2022-04-03 to 2022-07-02 | $1.70bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months, 2022-01-02 to 2022-07-02 | $3.41bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2022-04-03 to 2022-07-02 | $643.5m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2022-01-02 to 2022-07-02 | $1.28bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2022-04-03 to 2022-07-02 | $332.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2022-01-02 to 2022-07-02 | $687.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months, 2022-04-03 to 2022-07-02 | $20.8m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2022-01-02 to 2022-07-02 | $40.4m | us-gaap:InterestExpense |
| Income tax | 3 months, 2022-04-03 to 2022-07-02 | $73.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2022-01-02 to 2022-07-02 | $144.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2022-04-03 to 2022-07-02 | $214.5m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2022-01-02 to 2022-07-02 | $412.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2022-04-03 to 2022-07-02 | $2.61 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2022-01-02 to 2022-07-02 | $5.00 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2022-04-03 to 2022-07-02 | $2.63 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2022-01-02 to 2022-07-02 | $5.03 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2022-04-03 to 2022-07-02 | 82,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2022-01-02 to 2022-07-02 | 82,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2022-01-02 to 2022-07-02 | $394.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2022-01-02 to 2022-07-02 | $106.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2022-01-02 to 2022-07-02 | $117.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months, 2022-01-02 to 2022-07-02 | $268.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2022-07-02 | $164.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-07-02 | $2.95bn | us-gaap:AssetsCurrent |
| Total assets | at 2022-07-02 | $8.09bn | us-gaap:Assets |
| Current liabilities | at 2022-07-02 | $3.00bn | us-gaap:LiabilitiesCurrent |
| Current portion of debt | at 2022-07-02 | $738.6m | us-gaap:DebtCurrent |
| Shareholders' equity | at 2022-07-02 | $1.94bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 40,514 characters.

Management’s Discussion and Analysis of Financial Condition and Results of Operations, or MD&A, provides management’s views on our financial condition and results of operations and should be read in conjunction with the accompanying unaudited Condensed Consolidated Financial Statements and related notes.

### NON-GAAP FINANCIAL MEASURES

We report our financial results in conformity with accounting principles generally accepted in the United States of America, or GAAP, and also communicate with investors using certain non-GAAP financial measures. These non-GAAP financial measures are not in accordance with, nor are they a substitute for or superior to, the comparable GAAP financial measures. These non-GAAP financial measures are intended to supplement the presentation of our financial results prepared in accordance with GAAP. Based on feedback from investors and financial analysts, we believe that the supplemental non-GAAP financial measures we provide are useful to their assessments of our performance and operating trends, as well as liquidity.

Our non-GAAP financial measures exclude the impact of certain events, activities or strategic decisions. The accounting effects of these events, activities or decisions, which are included in the GAAP financial measures, may make it more difficult to assess our underlying performance in a single period. By excluding the accounting effects, positive or negative, of certain items (e.g., restructuring charges, outcomes of certain legal proceedings, certain effects of strategic transactions and related costs, losses from debt extinguishments, gains or losses from curtailment or settlement of pension obligations, gains or losses on sales of certain assets, gains or losses on venture investments and other items), we believe that we are providing meaningful supplemental information that facilitates an understanding of our core operating results and liquidity measures. While some of the items we exclude from GAAP financial measures recur, they tend to be disparate in amount, frequency or timing.

We use these non-GAAP financial measures internally to evaluate trends in our underlying performance, as well as to facilitate comparison to the results of competitors for quarters and year-to-date periods, as applicable.

We use the non-GAAP financial measures described below in this MD&A.

- *Sales change ex. currency* refers to the increase or decrease in net sales, excluding the estimated impact of foreign currency translation and the reclassification of sales between segments, and, where applicable, an extra week in our fiscal year and the calendar shift resulting from the extra week in the prior fiscal year, and currency adjustment for transitional reporting of highly inflationary economies. The estimated impact of foreign currency translation is calculated on a constant currency basis, with prior period results translated at current period average exchange rates to exclude the effect of currency fluctuations.
- *Organic sales change* refers to sales change ex. currency, excluding the estimated impact of acquisitions and product line divestitures.

We believe that sales change ex. currency and organic sales change assist investors in evaluating the sales change from the ongoing activities of our businesses and enhance their ability to evaluate our results from period to period.

- *Free cash flow* refers to cash flow provided by operating activities, less payments for property, plant and equipment, software and other deferred charges, plus proceeds from sales of property, plant and equipment, plus (minus) net proceeds from insurance and sales (purchases) of investments. Free cash flow is also adjusted for, where applicable, certain acquisition-related transaction costs. We believe that free cash flow assists investors by showing the amount of cash we have available for debt reductions, dividends, share repurchases and acquisitions.
- *Operational working capital as a percentage of annualized current quarter net sales* refers to trade accounts receivable and inventories, net of accounts payable, and excludes cash and cash equivalents, short-term borrowings, deferred taxes, other current assets and other current liabilities, as well as net current assets or liabilities held-for-sale divided by annualized current quarter net sales. We believe that operational working capital as a percentage of annualized current quarter net sales assists investors in assessing our working capital requirements because it excludes the impact of fluctuations attributable to our financing and other activities (which affect cash and cash equivalents, deferred taxes, other current assets and other current liabilities) that tend to be disparate in amount, frequency or timing, and may increase the volatility of working capital as a percentage of sales from period to period. The items excluded from this measure are not significantly influenced by our day-to-day activities managed at the operating level and do not necessarily reflect the underlying trends in our operations.

### OVERVIEW AND OUTLOOK

### Net Sales

The factors impacting the reported net sales change, as compared to the prior-year period, are shown in the table below.

|  | Three Months Ended July 2, 2022 | Six Months Ended July 2, 2022 |
| --- | ---: | ---: |
| Reported net sales change | 12% | 13% |
| Foreign currency translation | 5 | 4 |
| Sales change ex. currency(1) | 17 | 17 |
| Acquisitions | (5) | (5) |
| Organic sales change(1) | 11% | 12% |

(1) Totals may not sum due to rounding

In the three and six months ended July 2, 2022, net sales increased on an organic basis compared to the same period in the prior year due to pricing actions.

### Net Income

Net income increased from approximately $393 million in the first six months of 2021 to approximately $413 million in the first six months of 2022. Major factors affecting the change in net income included the following:

- Net benefit of pricing, freight and raw material costs
- Higher income from business acquisitions, net of associated amortization of other intangibles
- Higher organic volume/mix

Offsetting factors:

- Unfavorable foreign currency translation
- Growth investments
- Higher employee-related costs
- Higher tax provision

### Acquisitions

During January 2022, we completed our acquisitions of TexTrace AG ("TexTrace"), a Switzerland-based technology developer specializing in custom-made woven and knitted radio-frequency identification ("RFID") products that can be sewn onto or inserted into garments, and Rietveld Serigrafie B.V. and Rietveld Screenprinting Serigrafi Baski Matbaa Tekstil Ithalat Ihracat Sanayi ve Ticaret Limited Sirketi (collectively, "Rietveld"), a Netherlands-based provider of external embellishment solutions and application and printing methods for performance brands and team sports in Europe. These acquisitions expand the product portfolio in our Retail Branding and Information Solutions ("RBIS") reportable segment.

The acquisitions of TexTrace and Rietveld are referred to collectively as the "2022 Acquisitions."

The aggregate purchase consideration for the 2022 Acquisitions was approximately $35 million. We funded the 2022 Acquisitions using cash and commercial paper borrowings. In addition to the cash paid at closing, the sellers in one of these acquisitions are eligible for earn-out payments of up to $30 million, subject to the acquired company achieving certain post-acquisition performance targets. As of the acquisition date, we include an estimate of the fair value of these earn-out payments in the aggregate purchase consideration.

The 2022 Acquisitions were not material, individually or in the aggregate, to the unaudited Condensed Consolidated Financial Statements.

Refer to Note 2, “Acquisitions,” to the unaudited Condensed Consolidated Financial Statements for more information.

### Cost Reduction Actions

#### 2019/2020 Actions

During the six months ended July 2, 2022, we recorded $4 million in restructuring charges related to our 2019/2020 actions. These charges consisted of severance and related costs for the reduction of approximately 220 positions at numerous locations across our company. These actions, which were primarily taken in our RBIS reportable segment, largely related to global headcount and footprint reductions. Accruals for severance and related costs, as well as lease cancellation costs, were not material as of July 2, 2022.

Restructuring charges were included in “Other expense (income), net” in the unaudited Condensed Consolidated Statements of Income. Refer to Note 5, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information.

### Cash Flow

*(In millions)*

|  | Six Months Ended July 2, 2022 | July 3, 2021 |
| --- | ---: | ---: |
| Net cash provided by operating activities | $394.4 | $476.8 |
| Purchases of property, plant and equipment | (106.8) | (83.8) |
| Purchases of software and other deferred charges | (9.9) | (6.4) |
| Proceeds from sales of property, plant and equipment | 2.1 | 1.0 |
| Proceeds from insurance and sales (purchases) of investments, net | 2.0 | .4 |
| Payments for certain acquisition-related transaction costs | .6 | — |
| Free cash flow | $282.4 | $388.0 |

During the first six months of 2022, net cash provided by operating activities decreased compared to the same period last year primarily due to changes in operational working capital, higher incentive compensation payments and the timing of payroll payments, partially offset by higher net income and lower tax payments. During the first six months of 2022, free cash flow decreased compared to the same period last year primarily due to a decrease in net cash provided by operating activities and an increase in purchases of property, plant and equipment.

### Outlook

Certain factors that we believe may contribute to our 2022 results are described below.

- We expect net sales to increase by approximately 11%-12%, which includes a decrease of approximately 5% from the effect of foreign currency translation and an increase of approximately 3% from the effect of acquisitions.
- Based on recent exchange rates, we expect foreign currency translation to decrease our operating income by approximately $67 million.
- We expect our full year effective tax rate to be in the mid-20% range.
- We expect fixed and IT capital spend of up to $350 million.

### ANALYSIS OF RESULTS OF OPERATIONS FOR THE SECOND QUARTER

### Income Before Taxes

*(In millions, except percentages)*

|  | Three Months Ended July 2, 2022 | July 3, 2021 |
| --- | ---: | ---: |
| Net sales | $2,347.0 | $2,102.0 |
| Cost of products sold | 1,703.5 | 1,525.7 |
| Gross profit | 643.5 | 576.3 |
| Marketing, general and administrative expense | 332.7 | 307.0 |
| Other expense (income), net | 3.4 | (.6) |
| Interest expense | 20.8 | 16.0 |
| Other non-operating expense (income), net | (1.3) | (1.4) |
| Income before taxes | $287.9 | $255.3 |
| Gross profit margin | 27.4% | 27.4% |

#### Gross Profit Margin

Gross profit margin for the second quarter of 2022 was unchanged from the same period last year as the impact of higher volume/mix offset the net impact of pricing, freight and raw material costs, as well as higher employee-related costs.

#### Marketing, General and Administrative Expense

Marketing, general and administrative expense increased in the second quarter of 2022 compared to the same period last year primarily due to the impact of acquisitions, higher employee-related costs and growth investments, partially offset by favorable foreign currency translation.

#### Other Expense (Income), Net

*(In millions)*

| Other expense (income), net, by type Restructuring charges: | Three Months Ended July 2, 2022 | July 3, 2021 |
| --- | ---: | ---: |
| Severance and related costs | $3.1 | $1.6 |
| Asset impairment charges and lease cancellation costs | — | .1 |
| Other items: |  |  |
| Transaction and related costs | .1 | — |
| Outcomes of legal proceedings | .7 | (2.5) |
| (Gain) loss on sales of assets, net | (.5) | .2 |
| Other expense (income), net | $3.4 | $(.6) |

Refer to Note 5, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information regarding restructuring charges.

#### Interest Expense

Interest expense increased in the second quarter of 2022 compared to the same period last year, primarily as a result of additional interest costs related to the $800 million of senior notes we issued in August 2021.

### Net Income and Earnings per Share

*(In millions, except per share amounts and percentages)*

|  | Three Months Ended July 2, 2022 | July 3, 2021 |
| --- | ---: | ---: |
| Income before taxes | $287.9 | $255.3 |
| Provision for income taxes | 73.4 | 70.4 |
| Equity method investment (losses) gains | — | (1.1) |
| Net income | $214.5 | $183.8 |
| Per share amounts: |  |  |
| Net income per common share | $2.63 | $2.21 |
| Net income per common share, assuming dilution | 2.61 | 2.19 |
| Effective tax rate | 25.5% | 27.6% |

#### Provision for Income Taxes

Our effective tax rate for the three months ended July 2, 2022 decreased compared to the same period last year primarily due to a higher net discrete benefit from decreases in certain tax reserves, including interest and penalties, as a result of closing tax years. Refer to Note 7, “Taxes Based on Income,” to the unaudited Condensed Consolidated Financial Statements for more information.

### RESULTS OF OPERATIONS BY REPORTABLE SEGMENT FOR THE SECOND QUARTER

Operating income refers to income before taxes, interest and other non-operating expense (income), net.

### Label and Graphic Materials

*(In millions)*

|  | Three Months Ended July 2, 2022 | July 3, 2021 |
| --- | ---: | ---: |
| Net sales including intersegment sales | $1,521.7 | $1,400.9 |
| Less intersegment sales | (29.9) | (24.7) |
| Net sales | $1,491.8 | $1,376.2 |
| Operating income(1) | 226.3 | 228.1 |
| (1)Included charges associated with restructuring actions in both years and outcome of legal proceedings in 2021. | $.5 | $(28.5) |

18

#### Net Sales

The factors impacting reported net sales change are shown in the table below.

|  | Three Months Ended July 2, 2022 |
| --- | ---: |
| Reported net sales change | 8% |
| Foreign currency translation | 6 |
| Sales change ex. currency(1) | 14 |
| Organic sales change(1) | 15% |
| (1) Totals may not sum due to rounding |  |

In the second quarter of 2022, net sales increased on an organic basis compared to the same period in the prior year due to pricing actions, partially offset by lower volume/mix. On an organic basis, net sales increased by a mid-single digit rate in emerging markets, a high-teens rate in North America and over 20% in Western Europe.

#### Operating Income

Operating income decreased slightly in the second quarter of 2022 compared to the same period last year primarily due to the impact of the Brazilian indirect tax credit in the prior year, higher employee-related costs and unfavorable foreign currency translation, partially offset by the net benefit of pricing, freight and raw material costs.

### Retail Branding and Information Solutions

*(In millions)*

|  | Three Months Ended July 2, 2022 | July 3, 2021 |
| --- | ---: | ---: |
| Net sales including intersegment sales | $665.6 | $538.7 |
| Less intersegment sales | (8.1) | (9.4) |
| Net sales | $657.5 | $529.3 |
| Operating income(1) | 84.6 | 42.1 |
| (1)Included transaction and related costs in 2022, charges associated with restructuring actions and (gain) loss on sale of assets in both years and outcome of legal proceedings in 2021. | $1.3 | $27.5 |

#### Net Sales

The factors impacting reported net sales change are shown in the table below.

|  | Three Months Ended July 2, 2022 |
| --- | ---: |
| Reported net sales change | 24% |
| Reclassification of sales between segments | (1) |
| Foreign currency translation | 4 |
| Sales change ex. currency(1) | 27 |
| Acquisitions | (23) |
| Organic sales change(1) | 5% |
| (1) Totals may not sum due to rounding |  |

In the second quarter of 2022, on an organic basis, sales increased by a mid-teens rate in high value categories, partially offset by a low-single digit rate decrease in the base business.

#### Operating Income

Operating income increased in the second quarter of 2022 compared to the same period last year primarily due to the combined benefit of higher organic volume and acquisitions, the impact of the outcome of legal proceedings in the prior year and the net benefit of pricing, freight and raw material costs, partially offset by higher amortization of other intangibles resulting from business acquisitions, growth investments and higher employee-related costs.

### Industrial and Healthcare Materials

*(In millions)*

|  | Three Months Ended July 2, 2022 | July 3, 2021 |
| --- | ---: | ---: |
| Net sales including intersegment sales | $202.5 | $198.7 |
| Less intersegment sales | (4.8) | (2.2) |
| Net sales | $197.7 | $196.5 |
| Operating income(1) | 20.4 | 22.5 |
| (1) Included charges associated with restructuring actions in both years. | $.1 | $.5 |

#### Net Sales

The factors impacting reported net sales change are shown in the table below.

|  | Three Months Ended July 2, 2022 |
| --- | ---: |
| Reported net sales change | 1% |
| Foreign currency translation | 4 |
| Sales change ex. currency(1) | 5 |
| Acquisitions | 2 |
| Organic sales change(1) | 7% |
| (1) Totals may not sum due to rounding |  |

In the second quarter of 2022, net sales increased on an organic basis compared to the same period in the prior year by a high-teens rate in healthcare categories and a mid-single digit rate in industrial categories.

#### Operating Income

Operating income decreased in the second quarter of 2022 compared to the same period last year primarily due to lower volume/mix and higher employee-related costs, partially offset by the net benefit of pricing, freight and raw material costs.

### ANALYSIS OF RESULTS OF OPERATIONS FOR THE SIX MONTHS YEAR-TO-DATE

### Income Before Taxes

*(In millions, except percentages)*

|  | Six Months Ended July 2, 2022 | July 3, 2021 |
| --- | ---: | ---: |
| Net sales | $4,696.3 | $4,153.3 |
| Cost of products sold | 3,411.5 | 2,980.0 |
| Gross profit | 1,284.8 | 1,173.3 |
| Marketing, general and administrative expense | 687.7 | 619.3 |
| Other expense (income), net | 1.8 | .3 |
| Interest expense | 40.4 | 32.2 |
| Other non-operating expense (income), net | (2.7) | (2.7) |
| Income before taxes | $557.6 | $524.2 |
| Gross profit margin | 27.4% | 28.2% |

#### Gross Profit Margin

Gross profit margin for the first six months of 2022 decreased from the same period last year primarily due to net impact of pricing, freight and raw material costs, as well as higher employee-related costs, partially offset by the impact of higher volume/mix.

#### Marketing, General and Administrative Expense

Marketing, general and administrative expense increased in the first six months of 2022 compared to the same period last year primarily due to the impact of acquisitions, growth investments and higher employee-related costs, partially offset by favorable foreign currency translation.

#### Other Expense (Income), Net

*(In millions)*

| Other expense (income), net, by type Restructuring charges: | Six Months Ended July 2, 2022 | July 3, 2021 |
| --- | ---: | --- |
| Severance and related costs | $4.0 | $4.0 |
| Asset impairment charges and lease cancellation costs | — | .6 |
| Other items: |  |  |
| Transaction and related costs | .3 | .7 |
| Outcomes of legal proceedings, net | 1.7 | (.4) |
| (Gain) loss on sales of assets, net | (.5) | .2 |
| Gain on venture investment | (3.7) | — |
| Gain on sale of product line | — | (4.8) |
| Other expense (income), net | $1.8 | $.3 |

Refer to Note 5, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information regarding restructuring charges. Refer to Note 12, “Segment and Disaggregated Revenue Information,” to the unaudited Condensed Consolidated Financial Statements for more information regarding outcomes of legal proceedings.

#### Interest Expense

Interest expense increased in the first six months of 2022 compared to the same period last year, primarily as a result of additional interest costs related to the $800 million of senior notes we issued in August 2021.

### Net Income and Earnings per Share

*(In millions, except per share amounts and percentages)*

|  | Six Months Ended July 2, 2022 | July 3, 2021 |
| --- | ---: | ---: |
| Income before taxes | $557.6 | $524.2 |
| Provision for income taxes | 144.9 | 128.5 |
| Equity method investment (losses) gains | — | (2.4) |
| Net income | $412.7 | $393.3 |
| Per share amounts: |  |  |
| Net income per common share | $5.03 | $4.74 |
| Net income per common share, assuming dilution | 5.00 | 4.69 |
| Effective tax rate | 26.0% | 24.5% |

#### Provision for Income Taxes

Our effective tax rate for the six months ended July 2, 2022 increased compared to the same period last year primarily due to a discrete return-to-provision benefit during the six months ended July 3, 2021 related to the election made on our amended 2018 U.S. federal tax return. Refer to Note 7, “Taxes Based on Income,” to the unaudited Condensed Consolidated Financial Statements for more information.

We estimate our effective tax rate for fiscal year 2022 to be in the mid-20% range. Our effective tax rate can vary from quarter to quarter due to a variety of factors, such as changes in the mix of earnings in countries with differing statutory tax rates, changes in tax reserves, settlements of income tax audits, changes in tax laws and regulations, return-to-provision adjustments, tax impacts related to stock-based payments and execution of tax planning strategies.

### RESULTS OF OPERATIONS BY REPORTABLE SEGMENT FOR THE SIX MONTHS YEAR-TO-DATE

Operating income refers to income before taxes, interest and other non-operating expense (income), net.

### Label and Graphic Materials

*(In millions)*

|  | Six Months Ended July 2, 2022 | July 3, 2021 |
| --- | ---: | ---: |
| Net sales including intersegment sales | $3,030.6 | $2,799.5 |
| Less intersegment sales | (58.6) | (46.3) |
| Net sales | $2,972.0 | $2,753.2 |
| Operating income(1) | 433.5 | 454.3 |
| (1)Included gain on venture investment in 2022, charges associated with restructuring actions in both years and transaction and related costs, outcomes of legal proceedings and gain on sale of product line in 2021. | $(2.7) | $(30.4) |

#### Net Sales

The factors impacting reported net sales change are shown in the table below.

|  | Six Months Ended July 2, 2022 |
| --- | ---: |
| Reported net sales change | 8% |
| Foreign currency translation | 5 |
| Sales change ex. currency(1) | 13 |
| Organic sales change(1) | 13% |

(1) Totals may not sum due to rounding

In the first six months of 2022, net sales increased on an organic basis compared to the same period in the prior year due to pricing actions, partially offset by lower volume/mix. On an organic basis, net sales increased by a mid-single digit rate in emerging markets, a high-teens rate in North America and over 20% in Western Europe.

#### Operating Income

Operating income decreased in the first six months of 2022 compared to the same period last year primarily due to the impact of the Brazilian indirect tax credit in the prior year, unfavorable foreign currency translation and higher employee-related costs, partially offset by the net benefit of pricing, freight and raw material costs.

### Retail Branding and Information Solutions

*(In millions)*

|  | Six Months Ended July 2, 2022 | July 3, 2021 |
| --- | ---: | ---: |
| Net sales including intersegment sales | $1,355.6 | $1,029.7 |
| Less intersegment sales | (19.1) | (17.7) |
| Net sales | $1,336.5 | $1,012.0 |
| Operating income(1) | 174.9 | 102.1 |
| (1) Included charges associated with restructuring actions, outcome of legal proceedings, transaction and related costs and (gain) loss on sale of assets in both years. | $2.9 | $29.6 |

#### Net Sales

The factors impacting reported net sales change are shown in the table below.

|  | Six Months Ended July 2, 2022 |
| --- | ---: |
| Reported net sales change | 32% |
| Reclassification of sales between segments | (1) |
| Foreign currency translation | 3 |
| Sales change ex. currency(1) | 35 |
| Acquisitions | (23) |
| Organic sales change(1) | 12% |

(1) Totals may not sum due to rounding

In the first six months of 2022, on an organic basis, sales increased by over 20% in high value categories and by a mid-single digit rate in the base business.

Company-wide, on an organic basis, sales of Intelligent Labels solutions increased by roughly 20%.

#### Operating Income

Operating income increased in the first six months of 2022 compared to the same period last year primarily due to the combined benefit of higher organic volume and acquisitions and the impact of the outcome of legal proceedings in the prior year, partially offset by higher amortization of other intangibles resulting from business acquisitions, growth investments and employee-related costs.

### Industrial and Healthcare Materials

*(In millions)*

|  | Six Months Ended July 2, 2022 | July 3, 2021 |
| --- | ---: | ---: |
| Net sales including intersegment sales | $397.6 | $392.4 |
| Less intersegment sales | (9.8) | (4.3) |
| Net sales | $387.8 | $388.1 |
| Operating income(1) | 36.0 | 46.0 |
| (1) Included charges associated with restructuring actions in both years and transaction and related costs and gain on sale of assets in 2021. | $.1 | $.6 |

#### Net Sales

The factors impacting reported net sales change are shown in the table below.

|  | Six Months Ended July 2, 2022 |
| --- | ---: |
| Reported net sales change | —% |
| Foreign currency translation | 3 |
| Sales change ex. currency(1) | 3 |
| Acquisitions | 2 |
| Organic sales change(1) | 5% |

(1) Totals may not sum due to rounding

In the first six months of 2022, net sales increased on an organic basis compared to the same period in the prior year by a low-single digit rate in industrial categories and a mid-teens rate in healthcare categories.

#### Operating Income

Operating income decreased in the first six months of 2022 compared to the same period last year primarily due to lower volume/mix and higher employee-related costs, partially offset by the net benefit of pricing, freight and raw material costs.

### FINANCIAL CONDITION

### Liquidity

### Operating Activities

*(In millions)*

|  | Six months ended July 2, 2022 | July 3, 2021 |
| --- | ---: | ---: |
| Net income | $412.7 | $393.3 |
| Depreciation | 88.2 | 80.8 |
| Amortization | 57.0 | 28.8 |
| Provision for credit losses and sales returns | 23.9 | 17.5 |
| Stock-based compensation | 23.9 | 18.5 |
| Pension plan settlement loss | — | .4 |
| Deferred taxes and other non-cash taxes | 8.6 | 10.6 |
| Other non-cash expense and loss (income and gain), net | 15.0 | 13.8 |
| Changes in assets and liabilities and other adjustments | (234.9) | (86.9) |
| Net cash provided by operating activities | $394.4 | $476.8 |

During the first six months of 2022, net cash provided by operating activities decreased compared to the same period last year primarily due to changes in operational working capital, higher incentive compensation payments and the timing of payroll payments, partially offset by higher net income and lower tax payments.

### Investing Activities

*(In millions)*

|  | Six months ended July 2, 2022 | July 3, 2021 |
| --- | ---: | ---: |
| Purchases of property, plant and equipment | $(106.8) | $(83.8) |
| Purchases of software and other deferred charges | (9.9) | (6.4) |
| Proceeds from sales of property, plant and equipment | 2.1 | 1.0 |
| Proceeds from insurance and sales (purchases) of investments, net | 2.0 | .4 |
| Proceeds from sale of product line | — | 6.7 |
| Payments for acquisitions, net of cash acquired, and investments in businesses | (37.0) | (33.8) |
| Net cash used in investing activities | $(149.6) | $(115.9) |

#### Purchases of Property, Plant and Equipment

During the first six months of 2022, we primarily invested in buildings and equipment to support growth in certain countries in Europe, in the U.S. and in certain countries in Latin America for our Labels and Graphic Materials (“LGM”) reportable segment, in the U.S. for our IHM reportable segment, and in certain countries in Asia and the U.S. for our RBIS reportable segment. During the first six months of 2021, we primarily invested in equipment to support growth in the U.S. and certain countries in Europe and Asia for our LGM reportable segment, in the U.S. for our IHM reportable segment, and in certain countries in Asia for our RBIS reportable segment.

#### Purchases of Software and Other Deferred Charges

During the first six months of 2022, we primarily invested in information technology upgrades in the U.S. and Asia. During the first six months of 2021, we primarily invested in information technology upgrades in the U.S. and Europe.

#### Proceeds from Sale of Product Line

During the first six months of 2021, proceeds from the sale of a product line were in our LGM reportable segment.

#### Payments for Acquisitions, Net of Cash Acquired, and Investments in Businesses

During the first six months of 2022, we paid consideration, net of cash acquired, of approximately $30 million for the 2022 Acquisitions. We funded the 2022 Acquisitions using cash and commercial paper borrowings. During the first six months of 2021, we paid consideration, net of cash acquired, of approximately $32 million for acquisitions, which we funded using cash and commercial paper borrowings. We also made certain venture investments in the first six-months of both 2022 and 2021.

### Financing Activities

*(In millions)*

|  | Six months ended July 2, 2022 | July 3, 2021 |
| --- | ---: | ---: |
| Net increase (decrease) in borrowings with maturities of three months or less | $176.9 | $(36.2) |
| Repayments of long-term debt and finance leases | (3.4) | (3.1) |
| Dividends paid | (117.4) | (108.0) |
| Share repurchases | (268.7) | (95.0) |
| Net (tax withholding) proceeds related to stock-based compensation | (25.1) | (25.3) |
| Net cash used in financing activities | $(237.7) | $(267.6) |

#### Borrowings and Repayment of Debt

During the first six months of 2022 and 2021, our commercial paper borrowings were used to fund acquisitions, dividend payments, share repurchases, capital expenditures and other general corporate purposes.

Refer to Note 2, “Acquisitions,” and Note 4, “Debt,” to the unaudited Condensed Consolidated Financial Statements for more information.

#### Dividends Paid

We paid dividends of $1.43 per share in the first six months of 2022 compared to $1.30 per share in the same period last year. In April 2022, we increased our quarterly dividend rate to $.75 per share, representing an increase of approximately 10% from our previous quarterly dividend rate of $.68 per share.

#### Share Repurchases

During the first six months of 2022 and 2021, we repurchased approximately 1.5 million and 0.5 million shares of our common stock, respectively.

In April 2022, our Board authorized the repurchase of shares of our common stock with a fair market value of up to $750 million, excluding any fees, commissions or other expenses related to such purchases and in addition to the amount outstanding under our previous Board authorization. Board authorizations remain in effect until shares in the amount authorized thereunder have been repurchased. As of July 2, 2022, shares of our common stock in the aggregate amount of $840.8 million remained authorized for repurchase under our outstanding Board authorizations.

### Analysis of Selected Balance Sheet Accounts

#### Long-lived Assets

In the six months ended July 2, 2022, goodwill decreased by approximately $26 million to $1.86 billion, which reflected the impact of foreign currency translation, partially offset by the preliminary valuation of goodwill associated with the 2022 Acquisitions.

In the six months ended July 2, 2022, other intangibles resulting from business acquisitions, net, decreased by approximately $29 million to $882.6 million, which reflected current year amortization expense and the impact of foreign currency translation, partially offset by the preliminary valuation of intangible assets associated with the 2022 Acquisitions.

Refer to Note 3, “Goodwill and Other Intangibles Resulting from Business Acquisitions,” to the unaudited Condensed Consolidated Financial Statements for more information.

#### Shareholders’ Equity Accounts

As of July 2, 2022, the balance of our shareholders’ equity was $1.94 billion. Refer to Note 9, “Supplemental Equity and Comprehensive Income Information,” to the unaudited Condensed Consolidated Financial Statements for more information.

### Impact of Foreign Currency Translation

*(In millions)*

|  | Six Months Ended July 2, 2022 |
| --- | ---: |
| Change in net sales | $(150) |

International operations generated approximately 72% of our net sales during the six months ended July 2, 2022. Our future results are subject to changes in political and economic conditions in the regions in which we operate and the impact of fluctuations in foreign currency exchange and interest rates.

The unfavorable impact of foreign currency translation on net sales in the first six months of 2022 compared to the same period last year was primarily related to euro-denominated sales.

### Effect of Foreign Currency Transactions

The impact on net income from transactions denominated in foreign currencies is largely mitigated because the costs of our products are generally denominated in the same currencies in which they are sold. In addition, to reduce our income and cash flow exposure to transactions in foreign currencies, we enter into foreign exchange forward, option and swap contracts where available and appropriate. Refer to Note 6, “Financial Instruments,” to the unaudited Condensed Consolidated Financial Statements for more information.

### Analysis of Selected Financial Ratios

We utilize the financial ratios discussed below to assess our financial condition and operating performance. We believe this information assists our investors in understanding the drivers impacting our cash flow other than net income and capital expenditures.

#### Operational Working Capital Ratio

Operational working capital, as a percentage of annualized current-quarter net sales, is reconciled to working capital (deficit) below. Working capital (deficit) (current assets minus current liabilities) as of the second quarter 2022 decreased approximately $711 million compared to the second quarter of 2021 primarily due to higher commercial paper borrowings, the reclassification of the $250 million of senior notes due in the second quarter of 2023 and lower cash and cash equivalents, partially offset by an increase in operational working capital. Our objective is to minimize our investment in operational working capital, as a percentage of annualized current-quarter net sales, to maximize cash flow and return on investment. Operational working capital, as a percentage of annualized current-quarter net sales, in the second quarter of 2022 was higher compared to the second quarter of 2021.

*(In millions, except percentages)*

|  | July 2, 2022 | July 3, 2021 |
| --- | ---: | ---: |
| (A) Working capital (deficit) | $(51.7) | $659.1 |
| Reconciling items: |  |  |
| Cash and cash equivalents | (164.8) | (344.8) |
| Other current assets | (228.8) | (233.1) |
| Short-term borrowings and current portion of long-term debt and finance leases | 738.6 | 33.6 |
| Accrued payroll and employee benefits and other current liabilities | 851.0 | 822.4 |
| (B) Operational working capital | $1,144.3 | $937.2 |
| (C) Second-quarter net sales, annualized | $9,388.0 | $8,408.0 |
| Operational working capital, as a percentage of annualized current-quarter net sales: (B) ÷ (C) | 12.2% | 11.1% |

#### Accounts Receivable Ratio

The average number of days sales outstanding was 61 days in the second quarter of 2022 compared to 58 days in the second quarter of 2021, calculated using the accounts receivable balance at quarter-end divided by the average daily sales in the respective quarter. The increase in average number of days sales outstanding was primarily due to the timing of collections and impact of acquisitions, partially offset by foreign currency translation.

#### Inventory Ratio

Average inventory turnover was 6.9 in the second quarter of 2022 compared to 7.4 in the second quarter of 2021, calculated using the annualized second-quarter cost of products sold in 2022 and 2021, respectively, and divided by the inventory balance at quarter-end. The decrease in average inventory turnover primarily reflected increased inventory to manage through supply chain constraints.

#### Accounts Payable Ratio

The average number of days payable outstanding was 75 days in the second quarter of 2022 compared to 73 days in the second quarter of 2021, calculated using the accounts payable balance at quarter-end divided by the respective annualized second-quarter cost of products sold. The increase in average number of days payable outstanding primarily reflected higher accounts payable balances due to our increased inventory to manage through supply chain constraints, partially offset by the impact of acquisitions and foreign currency translation.

### Capital Resources

Capital resources include cash flows from operations, cash and cash equivalents and debt financing, including access to commercial paper borrowings supported by our Revolver. We use these resources to fund our operational needs.

As of July 2, 2022, we had cash and cash equivalents of $164.8 million held in accounts at third-party financial institutions. Our cash balances are held in numerous locations throughout the world. As of July 2, 2022, the majority of our cash and cash equivalents was held by our foreign subsidiaries, primarily in Asia Pacific.

To meet our U.S. cash requirements, we have several cost-effective liquidity options available. These options include borrowing funds at reasonable rates, including borrowings from foreign subsidiaries, and repatriating foreign earnings and profits. However, if we were to repatriate foreign earnings and profits, a portion would be subject to cash payments of withholding taxes imposed by foreign tax authorities. Additional U.S. taxes may also result from the impact of foreign currency fluctuations related to these earnings and profits.

The Revolver, which matures in February 2025, is used as a back-up facility for our commercial paper borrowings and can be used for other corporate purposes. No balance was outstanding under the Revolver as of July 2, 2022 or January 1, 2022.

We currently anticipate using cash flows from operations and commercial paper borrowings to repay approximately $250 million of senior notes maturing in the second quarter of 2023.

#### Capital from Debt

The carrying value of our total debt increased by approximately $127 million in the first six months of 2022 to $3.23 billion, primarily reflecting a net increase in commercial paper borrowings.

Credit ratings are a significant factor in our ability to raise short- and long-term financing. The credit ratings assigned to us also impact the interest rates we pay and our access to commercial paper, credit facilities and other borrowings. A downgrade of our short-term credit ratings could impact our ability to access commercial paper markets. If our access to commercial paper markets were to become limited, we believe that the Revolver and our other credit facilities would be available to meet our short-term funding requirements. When determining a credit rating, we believe that rating agencies primarily consider our competitive position, business outlook, consistency of cash flows, debt level and liquidity, geographic dispersion and management team. We remain committed to maintaining an investment grade rating.

### Off-Balance Sheet Arrangements, Contractual Obligations, and Other Matters

Refer to Note 11, “Commitments and Contingencies,” to the unaudited Condensed Consolidated Financial Statements for this information. Except as indicated therein, we have no material off-balance sheet arrangements as described in Item 303(b) of Regulation S-K.

## Market risk

As filed, 226 characters.

There have been no material changes to the information provided in Part II, Item 7A of our Annual Report on Form 10-K for the fiscal year ended January 1, 2022 that have not been disclosed in our periodic filings with the SEC.

## Controls and procedures

As filed, 2,313 characters.

### Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(f)) that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding the required disclosure.

In designing and evaluating the disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Our disclosure controls system is based upon a global chain of financial and general business reporting lines that converge in our headquarters in Mentor, Ohio. As required by SEC Rule 13a-15(b), we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the quarter covered by this report. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of such time to provide reasonable assurance that information was recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information was accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding the required disclosure.

### Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 3,850 characters.

There have been no material changes to the risk factors included in Part I, Item 1A, of our Annual Report on Form 10-K for the fiscal year ended January 1, 2022 that have not been disclosed in our periodic filings with the SEC, except as set forth below.

*The demand for our products is impacted by the effects of, and changes in, worldwide economic, social, political and market conditions, which could have a material adverse effect on our business.*

We have operations in over 50 countries and our domestic and international operations are strongly influenced by matters beyond our control, including changes in political, social, economic and labor conditions, tax laws (including U.S. taxes on foreign earnings), and international trade regulations (including tariffs), as well as the impact of these changes on the underlying demand for our products. In 2021, approximately 75% of our net sales were from international operations.

Macroeconomic developments such as impacts from COVID-19, inflation, raw material, freight and labor availability, slower growth in the geographic regions in which we operate and uncertainty in the global credit or financial markets leading to a loss of consumer confidence could result in a material adverse effect on our business as a result of, among other things, reduced consumer spending, declines in asset valuations, diminished liquidity and credit availability, volatility in securities prices, credit rating downgrades and fluctuations in foreign currency exchange rates.

We continue to face uncertainty from relations between the U.S. and China. Over the past few years, the U.S. government has imposed additional tariffs on products imported into the U.S. from China. This has resulted in reciprocal tariffs on goods imported from the U.S. into China. The impacts on our operations to date have not been significant. There remains risk that our business could be significantly impacted if additional tariffs or other restrictions are imposed on products. Any of these actions or further developments in international trade relations could have a material adverse effect on our business.

In addition, business and operational disruptions or delays caused by political, social or economic instability and unrest – such as civil, political and economic disturbances in places such as the U.S., Russia, Ukraine, Afghanistan, Syria, Iraq, Iran, Turkey, North Korea, Hong Kong and Sri Lanka and the related impact on global stability, terrorist attacks and the potential for other hostilities, public health crises or natural disasters in various parts of the world – could contribute to a climate of economic and political uncertainty that in turn could have a material adverse effect on our business. In February 2022, Russia invaded Ukraine resulting in the U.S., Canada, the European Union and other countries imposing economic sanctions on Russia. Additional potential sanctions and penalties have been proposed or threatened. Russian military actions and the resulting sanctions could adversely affect the global economy and financial markets. Any Russian response could also disrupt commercial and financial transactions. We have ceased shipment of all products for the Russian market. Our sales for the Russian market were approximately 1% of our net sales in 2021. Further, the continuing conflict in Ukraine has spilled over into neighboring countries due to the displacement of a large number of refugees, which could adversely impact the global supply chain and disrupt our operations or negatively impact the demand for our products in our primary end markets. Any such disruption could have a material adverse effect to our financial results.

We are not able to predict the duration and severity of adverse economic, social, political or market conditions in the U.S. or other countries.

Filed Aug 2, 2022.
Source: SEC EDGAR, the filing index for accession 0000008818-22-000012. Last ingested by Listed: Nov 10, 2026, 16:39 ET. No prices; not investment advice.
